Home › News and Press › Page 3

News and Press releases

View all News Press releases

Oxcia AB (publ) publishes annual report

May 16, 2023 · News and Press

Oxcia AB (publ) publishes interim report fort the first quarter 2023

April 26, 2023 · News and Press

Oxcia has been awarded a grant of 3 million SEK for a study in refractory AML patients

April 3, 2023 · News and Press

Three abstracts on OXC-101 selected for poster presentations at AACR 2023

March 30, 2023 · News and Press

New pre-clinical study shows that OXC-201 may be a promising treatment for IPF (pulmonary fibrosis)

March 2, 2023 · News and Press

The EIC has awarded Oxcia AB with a EIC transition grant of 2.5 million Euros for development of OXC-201.

February 24, 2023 · News and Press

Oxcia AB publishes Year-End Report for 2022

February 15, 2023 · News and Press

Attended DDR Inhibitors Summit in Boston

February 6, 2023 · News and Press

World Cancer Day

February 4, 2023 · News and Press

New article enforces the cancer cell selective killing of OXC-101

January 25, 2023 · News and Press

Oxcia attends DDR Inhibitors Summit in Boston

January 17, 2023 · News and Press

Data show OXC-201 may be a promising treatment for allergic asthma.

October 21, 2022 · News and Press

Search